top of page

INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE

Product details

Registration number: SIN14853P

Classification: Prescription Only

Active ingredients: Umeclidinium Bromide 74.2 mcg (micronised) eqv. Umeclidinium

Strength: 62.5 mcg/dose

Dosage form: POWDER, METERED

Route: RESPIRATORY (INHALATION)

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: R03BB07

HSA approval date: 21 September 2015

Manufacturer(s):

  • Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
  • GlaxoSmithKline LLC

Manufacturing country/countries: UNITED STATES; UNITED KINGDOM

What are the HSA registration number and classification for INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14853P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Umeclidinium Bromide 74.2 mcg (micronised) eqv. Umeclidinium

Strength: 62.5 mcg/dose

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE?

According to the HSA dataset updated 7 August 2026:

Dosage form: POWDER, METERED

Route: RESPIRATORY (INHALATION)

Source for this answer

Who is the recorded registrant for INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
  • GlaxoSmithKline LLC

Manufacturing country/countries: UNITED STATES; UNITED KINGDOM

Source for this answer

Where can I look up INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14853P or the exact product name INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE. The general register link does not preselect this product.

Source for this answer

What are the source dates for this INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14853P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page